|
Volumn 21, Issue 1, 2006, Pages 1-6
|
Diagnosis and management of the metabolic syndrome An American Heart Association/National Heart, Lung, and Blood Institute scientific statement
a a a a a a a a a a a a
a
NONE
|
Author keywords
AHA Scientific Statements; Atherosclerosis; Diabetes; Metabolic syndrome X; Risk factors
|
Indexed keywords
ACETYLSALICYLIC ACID;
BILE ACID SEQUESTRANT;
CLOPIDOGREL;
EZETIMIBE;
FIBRIC ACID DERIVATIVE;
FIBRINOGEN;
GEMFIBROZIL;
GLUCOSE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
NICOTINIC ACID;
PLASMINOGEN ACTIVATOR INHIBITOR 1;
ABDOMINAL OBESITY;
ACUTE PANCREATITIS;
ATHEROSCLEROSIS;
BLOOD PRESSURE MEASUREMENT;
CALORIC INTAKE;
CARDIOVASCULAR DISEASE;
CLINICAL FEATURE;
CLINICAL PRACTICE;
CORRELATION ANALYSIS;
DIAGNOSTIC PROCEDURE;
DYSLIPIDEMIA;
EXERCISE;
FIBRINOLYTIC THERAPY;
GLUCOSE BLOOD LEVEL;
HEALTH CARE ORGANIZATION;
HUMAN;
HYPERTRIGLYCERIDEMIA;
LIFESTYLE;
MEDICAL SOCIETY;
METABOLIC SYNDROME X;
MYOPATHY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
OBESITY;
PHYSICAL ACTIVITY;
PRIORITY JOURNAL;
REVIEW;
RISK ASSESSMENT;
RISK FACTOR;
THROMBOSIS;
WEIGHT REDUCTION;
AMERICAN HEART ASSOCIATION;
HUMANS;
METABOLIC SYNDROME X;
PRACTICE GUIDELINES;
UNITED STATES;
|
EID: 32044453773
PISSN: 02684705
EISSN: None
Source Type: Journal
DOI: 10.1113/jphysiol.2006.113472 Document Type: Review |
Times cited : (393)
|
References (0)
|